Sean Dolan
Impact in
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
- Hematology top 2%
- Blood Coagulation and Thrombosis Mechanisms
- Erythropoietin and Anemia Treatment
- Multiple Myeloma Research and Treatments
Papers in
- Hematology 19
- Chronic Myeloid Leukemia Treatments 6
- Multiple Myeloma Research and Treatments 6
- Erythropoietin and Anemia Treatment 4
- Genetics 12
- Chronic Lymphocytic Leukemia Research 12
- Co-authors
- David R. Anderson (6 shared papers)Michael J. Kovacs (5 shared papers)Jim A. Julian (3 shared papers)Jeffrey I. Weitz (3 shared papers)Paul Nguyen (3 shared papers)Christine Demers (3 shared papers)Susan Solymoss (3 shared papers)Michael Gent (3 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Blood (4 papers)BDJ (3 papers)HemaSphere (2 papers)Seminars in Oncology (2 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Sean Dolan
35 papers receiving 1.6k citations
Sean Dolan's Hit Papers
Peers
Comparison fields: 5 of 72
- Internal Medicine 680
- Hematology 590
- Genetics 433
- Emergency Medical Services 201
- Cardiology and Cardiovascular Medicine 460
Countries citing papers authored by Sean Dolan
This map shows the geographic impact of Sean Dolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Dolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Dolan more than expected).
Fields of papers citing papers by Sean Dolan
This network shows the impact of papers produced by Sean Dolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Dolan. The network helps show where Sean Dolan may publish in the future.
Co-authors
The 25 scholars most cited alongside Sean Dolan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism Hit paper breakdown → | 2003 | 573 |
| 2 | ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia Hit paper breakdown → | 2020 | 267 |
| 3 | 2005 | 255 | |
| 4 | 2001 | 132 | |
| 5 | 2008 | 87 | |
| 6 | 2022 | 70 | |
| 7 | 2006 | 62 | |
| 8 | 2004 | 48 | |
| 9 | 2007 | 34 | |
| 10 | 2003 | 26 | |
| 11 | 2017 | 22 | |
| 12 | 2019 | 21 | |
| 13 | 2004 | 17 | |
| 14 | 2021 | 15 | |
| 15 | 2016 | 15 | |
| 16 | 2021 | 12 | |
| 17 | 2006 | 10 | |
| 18 | 2002 | 9 | |
| 19 | 2004 | 8 | |
| 20 | 2017 | 7 |
About Sean Dolan
Sean Dolan is a scholar working on Hematology, Genetics, Molecular Biology, Pathology and Forensic Medicine and Internal Medicine, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (7 papers), Chronic Myeloid Leukemia Treatments (6 papers), Multiple Myeloma Research and Treatments (6 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Erythropoietin and Anemia Treatment (4 papers), Protein Degradation and Inhibitors (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Internal Medicine (680 citations), Hematology (590 citations), Genetics (433 citations), Emergency Medical Services (201 citations) and Cardiology and Cardiovascular Medicine (460 citations). Sean Dolan has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include David R. Anderson, Michael J. Kovacs, Jim A. Julian, Jeffrey I. Weitz, Paul Nguyen, Christine Demers, Susan Solymoss, Michael Gent, Jeffrey S. Ginsberg and William Geerts. Their work appears in journals such as Journal of Clinical Oncology, Blood, BDJ, HemaSphere and Seminars in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.